TRACON Pharmaceuticals Inc (NASDAQ: TCON) – Suitable For Long Term Buy?
Currently, there are 44.27M common shares owned by the public and among those 40.26M shares have been available to trade. However, the script later moved the day high at 0.4010, up 4.49%. The company’s stock has a 5-day price change of 21.76% and 142.87% over the past three months. TCON shares are trading 160.77% year […]
Reviewing The Case For TRACON Pharmaceuticals Inc (TCON) Going Higher
Currently, there are 44.27M common shares owned by the public and among those 41.31M shares have been available to trade. However, the script later moved the day high at 0.3800, down -3.71%. The company’s stock has a 5-day price change of 24.52% and 90.15% over the past three months. TCON shares are trading 106.23% year […]
TRACON Pharmaceuticals Inc (NASDAQ: TCON) Loses -82.19% From High. Why That Could Change?
Currently, there are 44.27M common shares owned by the public and among those 41.32M shares have been available to trade. The company’s stock has a 5-day price change of 108.00% and 107.12% over the past three months. TCON shares are trading 122.73% year to date (YTD), with the 12-month market performance down to -72.73% lower. […]
Is There More Upside Ahead For TRACON Pharmaceuticals Inc (NASDAQ: TCON)
TRACON Pharmaceuticals Inc (TCON) concluded trading on Thursday at a closing price of $0.23, with 6.94 million shares of worth about $1.6 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.32% during that period and on Thursday the price saw a gain of […]
TRACON Pharmaceuticals Inc (NASDAQ: TCON): Analyst View Points To Future Growth
BlackRock Fund Advisors has recently announced that it has increased stake in TRACON Pharmaceuticals Inc (NASDAQ:TCON) by 0.04%. After grabbing 0.27 million shares, the institutional investor is now in possession of 102.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.86% having worth around $46869.0. Moreover, Geode Capital […]
Better Times Ahead For TRACON Pharmaceuticals Inc (NASDAQ: TCON)?
BlackRock Fund Advisors has recently announced that it has increased stake in TRACON Pharmaceuticals Inc (NASDAQ:TCON) by 0.04%. After grabbing 0.27 million shares, the institutional investor is now in possession of 102.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.86% having worth around $54903.0. Moreover, Geode Capital […]
Tomorrow Is Not Likely To Be Same For TRACON Pharmaceuticals Inc (TCON)
BlackRock Fund Advisors has recently announced that it has increased stake in TRACON Pharmaceuticals Inc (NASDAQ:TCON) by 0.04%. After grabbing 0.27 million shares, the institutional investor is now in possession of 102.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.87% having worth around $47672.0. Moreover, Geode Capital […]